查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2016363

肩关节关节重建市场：依产品类型、材料类型、应用和最终用户划分－2026-2032年全球市场预测

Shoulder Replacement Market by Product Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，肩关节关节重建市场价值为 9.3232 亿美元，到 2026 年成长至 9.751 亿美元，到 2032 年达到 14.3554 亿美元，年复合成长率为 6.36%。

主要市场统计数据
基准年 2025 9.3232亿美元
预计年份：2026年 9.751亿美元
预测年份 2032 1,435,540,000 美元
复合年增长率 (%) 6.36%

对现代肩关节关节重建进行简要概述，将人口结构变化、临床适应和手术创新与不断发展的护理路径和相关人员的优先事项联繫起来。

肩关节关节重建手术的现况是将长期沿用的手术原则与植入设计、手术技术和手术全期护理方面的快速创新相结合。随着预期寿命的延长和患者期望的改变，肩关节关节重建手术的适应症正在不断扩大，涵盖了从退化性关节炎到复杂的肩旋板疾病等多种病症。临床医生需要在满足患者持续功能恢復的需求与最大限度地减少併发症、缩短恢復时间和优化长期治疗效果等挑战之间寻求平衡。

全面概述肩关节关节重建手术中正在变革的技术、流程和交付模式，以重新定义临床和商业性需求。

肩关节关节重建手术领域正经历一场变革，这得益于技术、临床和系统性因素的共同作用。植入形状和材料的进步拓展了可有效治疗的解剖范围，而精细的术前规划和术中导航系统的引入则提高了手术的精确性和可重复性。同时，反向植入的成熟正在重新定义肩肩迴旋肌损伤的治疗方法，改变转诊模式，并扩大手术适应症的范围。

美国近期关税变化如何重塑肩关节关节重建手术利害关係人的供应链、筹资策略和国内製造奖励。

美国近期关税调整对整个肩关节关节重建供应链产生了连锁反应，影响筹资策略和生产决策。部分整形外科组件进口关税的提高，增加了依赖复杂、全球采购子组件的医疗设备和植入的总到货成本。因此，采购部门和医院正在重新审视与供应商的合同，不仅关注单价，也关注总到货成本，并考虑签订长期采购合约以稳定供应和应对价格波动。

以细分市场为中心的洞察，将产品类型、临床适应症、医疗保健环境和既定理念与开发和部署中的实际意义联繫起来。

精准的市场区隔有助于明确临床需求与产品及通路策略之间的关联。根据产品类型，市场可分为解剖型植入、表面置换解决方案和反向几何系统。解剖型植入物可进一步细分为无柄和有柄设计，为外科医师提供基于骨质和重新置换策略的选择。表面置换则包括半表面置换和全表面置换，后者更受寻求保留骨骼治疗的年轻患者的青睐。无柄系统同样提供无柄和有柄两种类型，其适应症范围不断扩大，并彻底改变了肩肩旋板损伤的治疗流程。

美洲、欧洲、中东和非洲以及亚太地区的医疗保健趋势将如何影响部署模式、监管挑战和商业化策略的差异？

区域趋势正以不同的方式影响技术的应用、监管路径和商业策略。在美洲，成熟的私人医院体系、不断扩大的门诊手术能力以及日益注重价值的医疗环境正在塑造临床应用。因此，能够缩短住院时间并展现切实功能性成果的创新技术往往能更快地获得医疗机构的支持，而采购机构则更加关注可预测的供应链和服务伙伴关係关係。

主要企业和新兴企业的策略模式，结合植入创新、数位化和服务型模式，以确保临床部署和营运弹性。

肩关节关节重建手术领域的竞争格局呈现渐进式创新与策略性重新定位并存的特征。各公司正致力于研发差异化的植入形状、模组化设计以适应重新置换手术，以及旨在提高生物相容性和减少磨损的表面技术。同时，对用于术前规划和术后结果追踪的数位化工具的投入，正在创造超越植入本身的全新价值提案。

为高阶主管提供可操作的策略行动，以加速临床部署、加强供应链，并使产品系列适应不断变化的医疗保健模式和支付方期望。

肩关节关节重建领域的领导者必须在研发、商业策略和营运方面采取果断行动，以获得临床和系统性价值。首先，应优先考虑模组化平台，以实现分阶段升级并降低库存管理的复杂性。这将有助于控制物流成本，同时保持手术的柔软性。其次，应投资于临床医生教育和基于模拟的培训项目，以加速安全引入新型植入和手术流程，从而减少治疗结果的差异。

透明且检验的研究途径，结合对临床医生的检验、对政策和临床文献的审查以及反覆的专家验证，确保了可靠的主题见解。

这些研究结果是基于一项结构化且检验的研究，整合了第一手和第二手证据。第一手资料收集包括对在大学医院和社区医疗机构工作的肩关节外科医生、医院和门诊手术中心的采购经理以及参与产品开发和分销的医疗设备业高管进行结构化访谈。这些定性资讯用于了解临床决策标准、手术趋势和营运限制。

结论是：将临床创新、营运韧性和策略商业化作为支柱，为肩关节关节重建手术的未来成功奠定基础。

总而言之，肩关节关节重建手术正处于一个转折点，设计创新、精细化的诊疗路径和供应链策略正在融合，重塑临床实践和商业性机会。植入的模组化和先进的固定理念使得个人化手术方案成为可能，而数位化规划和结果追踪则提高了手术的精确度和术后管理水平。同时，医疗服务提供者偏好的改变和采购压力正迫使製造商和医疗服务提供者重新思考产品系列和交付模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：肩关节关节重建市场：依产品类型划分

  • 解剖学
    • 无柄
    • 带茎
  • 表面置换术
    • 半脸置换术
    • 整体表面置换术
  • 撤销
    • 无柄
    • 带茎

第九章：肩关节关节重建市场：依材料类型划分

  • 水泥固定型
  • 无水泥

第十章 肩关节关节重建市场：依应用领域划分

  • 缺血性坏死
  • 断裂
  • 骨关节炎
  • 类风湿性关节炎
  • 肩旋板骨关节炎

第十一章 肩关节关节重建市场：依最终使用者划分

  • 门诊手术中心
  • 医院
  • 整形外科诊所

第十二章 肩关节关节重建市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 肩关节关节重建市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 肩关节关节重建市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国肩关节关节重建市场

第十六章 中国肩关节关节重建市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Conmed Corporation
  • DePuy Synthes, Inc.
  • Enovis Corporation
  • Exactech, Inc.
  • LimaCorporate SpA
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0309FBC5117B

The Shoulder Replacement Market was valued at USD 932.32 million in 2025 and is projected to grow to USD 975.10 million in 2026, with a CAGR of 6.36%, reaching USD 1,435.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 932.32 million
Estimated Year [2026] USD 975.10 million
Forecast Year [2032] USD 1,435.54 million
CAGR (%) 6.36%

A concise orientation to modern shoulder arthroplasty that ties demographic shifts, clinical indications, and procedural innovation to evolving care pathways and stakeholder priorities

The landscape of shoulder replacement blends long-established surgical principles with accelerating innovation in implant design, surgical technique, and perioperative care. As life expectancy rises and patient expectations evolve, shoulder arthroplasty increasingly serves a wider set of indications, from degenerative osteoarthritis to complex rotator cuff arthropathy. Clinicians are balancing the desire for durable functional restoration with the imperative to minimize complications, shorten recovery time, and optimize long-term outcomes.

Recent years have seen a steady shift toward implant modularity and designs that accommodate varying bone quality and soft-tissue conditions. At the same time, surgical workflows are adapting to include enhanced imaging, patient-specific instrumentation, and more rigorous protocols for preoperative optimization and postoperative rehabilitation. These developments are complemented by trends in health systems that prioritize value through reduced length of stay and fewer readmissions, further encouraging innovation in outpatient pathways and streamlined perioperative management.

Consequently, stakeholders across the ecosystem-surgeons, device manufacturers, hospitals, ambulatory providers, and payers-now emphasize integrated approaches that combine technical excellence with data-driven care pathways. Looking ahead, surgical training, implant lifecycle management, and evidence generation will remain central to improving outcomes and expanding appropriate access to shoulder replacement procedures.

An integrated overview of the technological, procedural, and delivery-model revolutions reshaping shoulder replacement and redefining clinical and commercial imperatives

The shoulder replacement landscape is undergoing transformative shifts driven by converging technological, clinical, and systems-level forces. Advances in implant geometry and materials are increasing the range of anatomies that can be effectively treated, while augmented preoperative planning and intraoperative guidance systems are improving precision and reproducibility. At the same time, the maturation of reverse geometry implants has redefined treatment for rotator cuff deficient shoulders, altering referral patterns and expanding surgical candidacy.

Concurrently, procedural pathways are shifting toward less invasive approaches and ambulatory settings, supported by multimodal analgesia and standardized rehabilitation protocols. Digital tools are increasingly embedded in the care continuum; remote monitoring and outcome-tracking platforms enable longitudinal assessment and create opportunities for iterative device improvement. Meanwhile, supply chain resiliency and localized manufacturing initiatives are emerging as strategic priorities, incentivized by a mix of procurement policy changes and efforts to reduce lead times.

These dynamics are interacting with payer emphasis on value and clinician demand for robust clinical evidence. As a result, the sector is moving away from one-size-fits-all solutions toward differentiated offerings that target specific patient phenotypes and care delivery models. Over time, this realignment promises to enhance clinical outcomes and operational efficiency, provided stakeholders coordinate around adoption, reimbursement, and training.

How recent United States tariff shifts have reconfigured supply chains, procurement strategies, and domestic manufacturing incentives for shoulder replacement stakeholders

Recent tariff adjustments in the United States have created a ripple effect across the shoulder replacement supply chain, influencing procurement strategies and manufacturing decisions. Increased import duties on certain orthopaedic components have elevated landed costs for devices and implants that rely on complex, globally sourced subassemblies. As a consequence, purchasing organizations and hospitals are re-evaluating supplier contracts, emphasizing total landed cost rather than unit price alone, and exploring longer-term sourcing agreements to stabilize supply and price volatility.

In response, some manufacturers are accelerating efforts to localize production, either by expanding domestic manufacturing capacity or by qualifying nearer-shore suppliers for critical components. These shifts reduce exposure to cross-border tariff changes and can shorten lead times, but they also require capital investment and meticulous supplier qualification to maintain quality standards. Additionally, tariffs have prompted stakeholders to scrutinize product portfolios, prioritizing high-value SKUs and modular systems that minimize the need for extensive inventories.

From a clinical operations perspective, procurement teams are collaborating more closely with clinical leadership to balance cost containment with device availability. Transitional strategies include inventory pooling, longer supplier contracts with fixed-price clauses, and increased focus on instruments and implants that deliver demonstrated clinical benefits per episode of care. Collectively, these measures aim to mitigate disruption while preserving access to essential shoulder replacement technologies.

Segment-focused insights that connect product types, clinical indications, care settings, and fixation philosophies to practical implications for development and adoption

A nuanced understanding of segmentation clarifies where clinical need intersects with product and channel strategy. Based on product type, the landscape encompasses anatomic implants, resurfacing solutions, and reverse geometry systems. Anatomic options further divide into stemless and stemmed designs, offering surgeons choices tied to bone quality and revision strategies, while resurfacing includes hemi resurfacing and total resurfacing approaches that appeal to younger patients seeking bone-preserving alternatives. Reverse systems, available in stemless and stemmed variants, have expanded indications and altered treatment algorithms for rotator cuff deficient shoulders.

When considering application, clinical drivers span avascular necrosis, fractures, osteoarthritis, rheumatoid arthritis, and rotator cuff arthropathy, each presenting distinct technical demands and postoperative pathways. These indications inform implant selection, fixation philosophy, and rehabilitation planning. Regarding end users, the procedural setting matters: ambulatory surgical centers are increasingly treating straightforward primary cases to realize efficiencies, hospitals continue to manage complex reconstructions and revisions, and orthopedic clinics play a central role in preoperative optimization and longitudinal follow-up.

Material type considerations, particularly cemented versus cementless fixation, remain central to clinical decision-making. Cementless technologies appeal where bone quality permits biologic fixation and the desire to preserve bone stock is paramount, whereas cemented fixation retains a role in osteoporotic contexts or when immediate stability is essential. Together, these intersecting dimensions shape product development priorities, clinical training requirements, and procurement strategies.

How regional healthcare dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated adoption patterns, regulatory challenges, and commercialization tactics

Regional dynamics influence adoption, regulatory pathways, and commercial strategy in distinct ways. In the Americas, clinical uptake is shaped by a mature private hospital sector, growing ambulatory surgery capacity, and a payer environment that increasingly rewards value-based pathways. Consequently, innovations that reduce length of stay and demonstrate robust functional outcomes tend to garner faster institutional support, while procurement organizations focus on predictable supply and service partnerships.

Across Europe, the Middle East and Africa, regulatory complexity and heterogeneous reimbursement landscapes create variability in adoption. Some countries emphasize centralized tendering and cost containment, which drives demand for durable, cost-effective solutions, while others prioritize rapid adoption of cutting-edge technologies when clinical benefits are clear. In parallel, capacity constraints and varying surgical volumes in parts of the region underscore opportunities for mobile training programs and product platforms that can be tailored to diverse clinical settings.

Asia-Pacific exhibits a heterogeneous but rapidly evolving picture. Growing healthcare investment, expanding elective surgical capacity, and local manufacturing initiatives are accelerating access to shoulder replacement technologies. In many jurisdictions, younger patient demographics and rising demand for function-restoring procedures are prompting manufacturers to pursue localization strategies, regulatory harmonization, and collaborations that strengthen distribution and surgeon training. Taken together, these regional trends require differentiated commercial models that account for procurement practices, clinician education, and logistical realities.

Strategic patterns among leading and emerging companies that combine implant innovation, digital enablement, and service-based models to secure clinical adoption and operational resilience

Competitive dynamics in shoulder replacement are characterized by a mix of incremental innovation and strategic repositioning. Companies are investing in differentiated implant geometries, modularity to accommodate revision scenarios, and surface technologies that aim to improve biological integration or reduce wear. Parallel investments in digital tools for preoperative planning and postoperative outcomes tracking are creating new value propositions that extend beyond the implant itself.

Strategically, leaders are balancing product development with service offerings that enhance surgeon adoption and case outcomes. This includes training academies, virtual simulation platforms, and evidence-generation partnerships with academic centers. At the same time, firms are rethinking commercial models to address the increasing importance of ambulatory settings and bundled payment arrangements. Partnerships and selective in-licensing accelerate access to novel materials or navigation technologies, while targeted acquisitions can fill gaps in digital capabilities or expand geographic reach.

For emerging entrants, differentiation often relies on niche clinical positioning-such as bone-preserving resurfacing or stemless reverse solutions-and on demonstrating clear procedural or economic advantages through real-world evidence. Across the board, operational excellence in manufacturing quality, supply chain resilience, and regulatory compliance remains a non-negotiable element of competitive success.

Practical strategic actions for executives to accelerate clinical adoption, fortify supply chains, and align product portfolios with evolving care models and payer expectations

Leaders in the shoulder replacement sector must act decisively across R&D, commercial strategy, and operational domains to capture clinical and system-level value. First, prioritize modular platforms that allow incremental upgrades and reduce inventory complexity; this supports procedural flexibility while containing logistics costs. Second, invest in clinician education and simulation-based training programs to accelerate safe adoption of new implants and surgical workflows, thereby reducing variability in outcomes.

Third, strengthen supply chain resilience by diversifying qualified suppliers and exploring near-shoring for critical components; doing so mitigates exposure to tariff-driven volatility and shortens replenishment cycles. Fourth, integrate digital planning and remote monitoring tools into product offerings to deliver measurable improvements in alignment, rehabilitation adherence, and long-term outcome capture. Fifth, align evidence-generation efforts with payer needs by designing pragmatic registries and real-world studies that demonstrate comparative clinical performance and patient-centered benefits.

Finally, pursue commercial models that reflect care-setting shifts, including targeted ambulatory strategies and outcome-based contracting where feasible. By combining these actions with disciplined portfolio management and selective partnerships, organizations can enhance adoption, reduce operational risk, and position themselves for sustained clinical relevance.

A transparent and auditable research approach combining clinician interviews, policy and clinical literature review, and iterative expert validation to ensure robust thematic findings

The research behind these insights synthesizes primary and secondary evidence using a structured and auditable approach. Primary data collection included structured interviews with practicing shoulder surgeons across academic and community settings, procurement leaders in hospitals and ambulatory surgical centers, and device industry executives involved in product development and distribution. These qualitative inputs were used to capture real-world decision criteria, procedural trends, and operational constraints.

Secondary research encompassed peer-reviewed clinical literature, specialty society guidelines, regulatory filings, and publicly available policy documents that frame reimbursement and procurement frameworks. Data triangulation combined these sources to validate thematic findings and to identify areas of consensus and divergence across stakeholders. Throughout the process, attention was paid to geographic nuance, ensuring that regional regulatory and delivery-model differences were explicitly considered.

Quality assurance measures included cross-validation of interview findings with clinical opinion leaders and iterative reviews by subject-matter experts to minimize bias. Limitations are acknowledged where evidence is emergent, and recommended future work includes targeted registries and prospective comparative studies to strengthen long-term outcome understanding.

Concluding synthesis linking clinical innovation, operational resilience, and strategic commercialization as the foundational pillars for future success in shoulder replacement

In synthesis, shoulder replacement is at an inflection point where design innovation, refined care pathways, and supply chain strategy converge to reshape clinical practice and commercial opportunity. Implant modularity and advanced fixation concepts are enabling tailored surgical solutions, while digital planning and outcome tracking are enhancing procedural precision and postoperative management. At the same time, evolving care-site preferences and procurement pressures are prompting manufacturers and providers to rethink product portfolios and delivery models.

Tariff-related shifts have underscored the importance of supply chain agility and the potential benefits of manufacturing localization, while regional heterogeneity demands flexible commercialization strategies that respect regulatory and reimbursement realities. For stakeholders seeking to navigate this environment successfully, combining clinical evidence generation with robust operational planning and targeted clinician engagement will be essential. Ultimately, the organizations that integrate technical innovation with value-focused service models and resilient supply chains will be best positioned to deliver improved patient outcomes and sustainable commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Shoulder Replacement Market, by Product Type

  • 8.1. Anatomic
    • 8.1.1. Stemless
    • 8.1.2. Stemmed
  • 8.2. Resurfacing
    • 8.2.1. Hemi Resurfacing
    • 8.2.2. Total Resurfacing
  • 8.3. Reverse
    • 8.3.1. Stemless
    • 8.3.2. Stemmed

9. Shoulder Replacement Market, by Material Type

  • 9.1. Cemented
  • 9.2. Cementless

10. Shoulder Replacement Market, by Application

  • 10.1. Avascular Necrosis
  • 10.2. Fractures
  • 10.3. Osteoarthritis
  • 10.4. Rheumatoid Arthritis
  • 10.5. Rotator Cuff Arthropathy

11. Shoulder Replacement Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Orthopedic Clinics

12. Shoulder Replacement Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Shoulder Replacement Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Shoulder Replacement Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Shoulder Replacement Market

16. China Shoulder Replacement Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Conmed Corporation
  • 17.7. DePuy Synthes, Inc.
  • 17.8. Enovis Corporation
  • 17.9. Exactech, Inc.
  • 17.10. LimaCorporate S.p.A.
  • 17.11. MicroPort Scientific Corporation
  • 17.12. Smith & Nephew plc
  • 17.13. Stryker Corporation
  • 17.14. Wright Medical Group N.V.
  • 17.15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SHOULDER REPLACEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SHOULDER REPLACEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 143. GCC SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 144. GCC SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 175. NATO SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 176. NATO SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)